Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

134 ARTÍCULOS , VIENDO DEL 1 AL 15

Alzheimer's disease and the quest for its biological measures

Praticò D.

J Alzheimers Dis. 2013;33 Suppl 1:S237-41. doi: 10.3233/JAD-2012-129023.

Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?

Zetterberg H, Blennow K.

J Alzheimers Dis. 2013;33 Suppl 1:S361-9. doi: 10.3233/JAD-2012-129035.

Trait, state, and mechanism: looking back, looking forward, and understanding why

Lovestone S.

J Alzheimers Dis. 2013;33 Suppl 1:S23-33. doi: 10.3233/JAD-2012-129014.

Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease

Teipel SJ, Sabri O, Grothe M, Barthel H, Prvulovic D, Buerger K, Bokde AL, Ewers M, Hoffmann W, Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S329-47. doi: 10.3233/JAD-2012-129030.

Biomarkers for Alzheimer's disease: showing the way or leading us astray?

Quinn JF.

J Alzheimers Dis. 2013;33 Suppl 1(Suppl 1):S371-6. doi: 10.3233/JAD-2012-129022.

Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease

Pacheco-Quinto J, Herdt A, Eckman CB, Eckman EA.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S101-10. doi: 10.3233/JAD-2012-129043.

Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia

Le Bastard N, Coart E, Vanderstichele H, Vanmechelen E, Martin JJ, Engelborghs S.

J Alzheimers Dis. 2013;33(1):117-31. doi: 10.3233/JAD-2012-121246.

Modulation of murine Alzheimer pathogenesis and behavior by surgery

Tang JX, Mardini F, Janik LS, Garrity ST, Li RQ, Bachlani G, Eckenhoff RG, Eckenhoff MF.

Ann Surg. 2013 Mar;257(3):439-48. doi: 10.1097/SLA.0b013e318269d623.

At the end of a very hard day, people find some reason to believe

Robert P.

J Alzheimers Dis. 2013;34(1):295-6. doi: 10.3233/JAD-121637.

Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study

Gabelle A, Dumurgier J, Vercruysse O, Paquet C, Bombois S, Laplanche JL, Peoc'h K, Schraen S, Buée L, Pasquier F, Hugon J, Touchon J, Lehmann S.

J Alzheimers Dis. 2013;34(1):297-305. doi: 10.3233/JAD-121549.

Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients

Laske C, Schmohl M, Leyhe T, Stransky E, Maetzler W, Berg D, Fallgatter AJ, Joos T, Dietzsch J.

J Alzheimers Dis. 2013;34(2):367-75. doi: 10.3233/JAD-121558.

Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials

Barnes J, Bartlett JW, Fox NC, Schott JM.

J Alzheimers Dis. 2013;34(2):431-7. doi: 10.3233/JAD-121936.

Blood transcriptomic biomarkers of Alzheimer's disease patients treated with EHT 0202

Désiré L, Blondiaux E, Carrière J, Haddad R, Sol O, Fehlbaum-Beurdeley P, Einstein R, Zhou W, Pando MP.

J Alzheimers Dis. 2013;34(2):469-83. doi: 10.3233/JAD-121501.

[A new definition for Alzheimer's disease]

Dubois B.

Bull Acad Natl Med. 2013 Jan;197(1):143-53; discussion 153-6.

Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review

Arevalo-Rodriguez I, Pedraza OL, Rodríguez A, Sánchez E, Gich I, Solà I, Bonfill X, Alonso-Coello P.

Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):111-9. doi: 10.1177/1533317512470209. Epub 2013 Jan 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias